Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 times?
Identifieur interne : 000898 ( Main/Exploration ); précédent : 000897; suivant : 000899Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 times?
Auteurs : Miranda Van Berkel [Pays-Bas] ; Matthijs Kox [Pays-Bas] ; Tim Frenzel [Pays-Bas] ; Peter Pickkers [Pays-Bas] ; Jeroen Schouten [Pays-Bas]Source :
- Critical care (London, England) [ 1466-609X ] ; 2020.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen (MeSH), Antibactériens (usage thérapeutique), Femelle (MeSH), Gestion responsable des antimicrobiens (MeSH), Humains (MeSH), Infections à coronavirus (sang), Infections à coronavirus (traitement médicamenteux), Infections à coronavirus (épidémiologie), Marqueurs biologiques (sang), Mâle (MeSH), Pandémies (MeSH), Pneumopathie virale (sang), Pneumopathie virale (épidémiologie), Procalcitonine (sang), Protéine C-réactive (analyse), Sujet âgé (MeSH).
- MESH :
- analyse : Protéine C-réactive.
- sang : Infections à coronavirus, Marqueurs biologiques, Pneumopathie virale, Procalcitonine.
- traitement médicamenteux : Infections à coronavirus.
- usage thérapeutique : Antibactériens.
- épidémiologie : Infections à coronavirus, Pneumopathie virale.
- Adulte d'âge moyen, Femelle, Gestion responsable des antimicrobiens, Humains, Mâle, Pandémies, Sujet âgé.
English descriptors
- KwdEn :
- Aged (MeSH), Anti-Bacterial Agents (therapeutic use), Antimicrobial Stewardship (MeSH), Biomarkers (blood), C-Reactive Protein (analysis), Coronavirus Infections (blood), Coronavirus Infections (drug therapy), Coronavirus Infections (epidemiology), Female (MeSH), Humans (MeSH), Male (MeSH), Middle Aged (MeSH), Pandemics (MeSH), Pneumonia, Viral (blood), Pneumonia, Viral (epidemiology), Procalcitonin (blood).
- MESH :
- chemical , analysis : C-Reactive Protein.
- chemical , blood : Biomarkers, Procalcitonin.
- chemical , therapeutic use : Anti-Bacterial Agents.
- blood : Coronavirus Infections, Pneumonia, Viral.
- drug therapy : Coronavirus Infections.
- epidemiology : Coronavirus Infections, Pneumonia, Viral.
- Aged, Antimicrobial Stewardship, Female, Humans, Male, Middle Aged, Pandemics.
DOI: 10.1186/s13054-020-03291-w
PubMed: 33023606
PubMed Central: PMC7538269
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 times?</title>
<author><name sortKey="Van Berkel, Miranda" sort="Van Berkel, Miranda" uniqKey="Van Berkel M" first="Miranda" last="Van Berkel">Miranda Van Berkel</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Laboratory Medicine, Radboud University Medical Centre, 6500 HB, Nijmegen, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Laboratory Medicine, Radboud University Medical Centre, 6500 HB, Nijmegen</wicri:regionArea>
<placeName><settlement type="city">Nimègue</settlement>
<region type="province" nuts="2">Gueldre</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kox, Matthijs" sort="Kox, Matthijs" uniqKey="Kox M" first="Matthijs" last="Kox">Matthijs Kox</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Intensive Care Medicine, Radboud University Medical Centre, Postbus 9101, 6500 HB, Nijmegen, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Intensive Care Medicine, Radboud University Medical Centre, Postbus 9101, 6500 HB, Nijmegen</wicri:regionArea>
<placeName><settlement type="city">Nimègue</settlement>
<region type="province" nuts="2">Gueldre</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Radboud Center for Infectious Diseases, Radboud University Medical Center, 6500 HB, Nijmegen, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Radboud Center for Infectious Diseases, Radboud University Medical Center, 6500 HB, Nijmegen</wicri:regionArea>
<placeName><settlement type="city">Nimègue</settlement>
<region type="province" nuts="2">Gueldre</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Frenzel, Tim" sort="Frenzel, Tim" uniqKey="Frenzel T" first="Tim" last="Frenzel">Tim Frenzel</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Intensive Care Medicine, Radboud University Medical Centre, Postbus 9101, 6500 HB, Nijmegen, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Intensive Care Medicine, Radboud University Medical Centre, Postbus 9101, 6500 HB, Nijmegen</wicri:regionArea>
<placeName><settlement type="city">Nimègue</settlement>
<region type="province" nuts="2">Gueldre</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Radboud Center for Infectious Diseases, Radboud University Medical Center, 6500 HB, Nijmegen, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Radboud Center for Infectious Diseases, Radboud University Medical Center, 6500 HB, Nijmegen</wicri:regionArea>
<placeName><settlement type="city">Nimègue</settlement>
<region type="province" nuts="2">Gueldre</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Pickkers, Peter" sort="Pickkers, Peter" uniqKey="Pickkers P" first="Peter" last="Pickkers">Peter Pickkers</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Intensive Care Medicine, Radboud University Medical Centre, Postbus 9101, 6500 HB, Nijmegen, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Intensive Care Medicine, Radboud University Medical Centre, Postbus 9101, 6500 HB, Nijmegen</wicri:regionArea>
<placeName><settlement type="city">Nimègue</settlement>
<region type="province" nuts="2">Gueldre</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Radboud Center for Infectious Diseases, Radboud University Medical Center, 6500 HB, Nijmegen, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Radboud Center for Infectious Diseases, Radboud University Medical Center, 6500 HB, Nijmegen</wicri:regionArea>
<placeName><settlement type="city">Nimègue</settlement>
<region type="province" nuts="2">Gueldre</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Schouten, Jeroen" sort="Schouten, Jeroen" uniqKey="Schouten J" first="Jeroen" last="Schouten">Jeroen Schouten</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Intensive Care Medicine, Radboud University Medical Centre, Postbus 9101, 6500 HB, Nijmegen, The Netherlands. jeroen.schouten@radboudumc.nl.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Intensive Care Medicine, Radboud University Medical Centre, Postbus 9101, 6500 HB, Nijmegen</wicri:regionArea>
<placeName><settlement type="city">Nimègue</settlement>
<region type="province" nuts="2">Gueldre</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Radboud Center for Infectious Diseases, Radboud University Medical Center, 6500 HB, Nijmegen, The Netherlands. jeroen.schouten@radboudumc.nl.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Radboud Center for Infectious Diseases, Radboud University Medical Center, 6500 HB, Nijmegen</wicri:regionArea>
<placeName><settlement type="city">Nimègue</settlement>
<region type="province" nuts="2">Gueldre</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:33023606</idno>
<idno type="pmid">33023606</idno>
<idno type="doi">10.1186/s13054-020-03291-w</idno>
<idno type="pmc">PMC7538269</idno>
<idno type="wicri:Area/Main/Corpus">000015</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000015</idno>
<idno type="wicri:Area/Main/Curation">000015</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000015</idno>
<idno type="wicri:Area/Main/Exploration">000015</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 times?</title>
<author><name sortKey="Van Berkel, Miranda" sort="Van Berkel, Miranda" uniqKey="Van Berkel M" first="Miranda" last="Van Berkel">Miranda Van Berkel</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Laboratory Medicine, Radboud University Medical Centre, 6500 HB, Nijmegen, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Laboratory Medicine, Radboud University Medical Centre, 6500 HB, Nijmegen</wicri:regionArea>
<placeName><settlement type="city">Nimègue</settlement>
<region type="province" nuts="2">Gueldre</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kox, Matthijs" sort="Kox, Matthijs" uniqKey="Kox M" first="Matthijs" last="Kox">Matthijs Kox</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Intensive Care Medicine, Radboud University Medical Centre, Postbus 9101, 6500 HB, Nijmegen, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Intensive Care Medicine, Radboud University Medical Centre, Postbus 9101, 6500 HB, Nijmegen</wicri:regionArea>
<placeName><settlement type="city">Nimègue</settlement>
<region type="province" nuts="2">Gueldre</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Radboud Center for Infectious Diseases, Radboud University Medical Center, 6500 HB, Nijmegen, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Radboud Center for Infectious Diseases, Radboud University Medical Center, 6500 HB, Nijmegen</wicri:regionArea>
<placeName><settlement type="city">Nimègue</settlement>
<region type="province" nuts="2">Gueldre</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Frenzel, Tim" sort="Frenzel, Tim" uniqKey="Frenzel T" first="Tim" last="Frenzel">Tim Frenzel</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Intensive Care Medicine, Radboud University Medical Centre, Postbus 9101, 6500 HB, Nijmegen, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Intensive Care Medicine, Radboud University Medical Centre, Postbus 9101, 6500 HB, Nijmegen</wicri:regionArea>
<placeName><settlement type="city">Nimègue</settlement>
<region type="province" nuts="2">Gueldre</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Radboud Center for Infectious Diseases, Radboud University Medical Center, 6500 HB, Nijmegen, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Radboud Center for Infectious Diseases, Radboud University Medical Center, 6500 HB, Nijmegen</wicri:regionArea>
<placeName><settlement type="city">Nimègue</settlement>
<region type="province" nuts="2">Gueldre</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Pickkers, Peter" sort="Pickkers, Peter" uniqKey="Pickkers P" first="Peter" last="Pickkers">Peter Pickkers</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Intensive Care Medicine, Radboud University Medical Centre, Postbus 9101, 6500 HB, Nijmegen, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Intensive Care Medicine, Radboud University Medical Centre, Postbus 9101, 6500 HB, Nijmegen</wicri:regionArea>
<placeName><settlement type="city">Nimègue</settlement>
<region type="province" nuts="2">Gueldre</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Radboud Center for Infectious Diseases, Radboud University Medical Center, 6500 HB, Nijmegen, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Radboud Center for Infectious Diseases, Radboud University Medical Center, 6500 HB, Nijmegen</wicri:regionArea>
<placeName><settlement type="city">Nimègue</settlement>
<region type="province" nuts="2">Gueldre</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Schouten, Jeroen" sort="Schouten, Jeroen" uniqKey="Schouten J" first="Jeroen" last="Schouten">Jeroen Schouten</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Intensive Care Medicine, Radboud University Medical Centre, Postbus 9101, 6500 HB, Nijmegen, The Netherlands. jeroen.schouten@radboudumc.nl.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Intensive Care Medicine, Radboud University Medical Centre, Postbus 9101, 6500 HB, Nijmegen</wicri:regionArea>
<placeName><settlement type="city">Nimègue</settlement>
<region type="province" nuts="2">Gueldre</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Radboud Center for Infectious Diseases, Radboud University Medical Center, 6500 HB, Nijmegen, The Netherlands. jeroen.schouten@radboudumc.nl.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Radboud Center for Infectious Diseases, Radboud University Medical Center, 6500 HB, Nijmegen</wicri:regionArea>
<placeName><settlement type="city">Nimègue</settlement>
<region type="province" nuts="2">Gueldre</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Critical care (London, England)</title>
<idno type="eISSN">1466-609X</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged (MeSH)</term>
<term>Anti-Bacterial Agents (therapeutic use)</term>
<term>Antimicrobial Stewardship (MeSH)</term>
<term>Biomarkers (blood)</term>
<term>C-Reactive Protein (analysis)</term>
<term>Coronavirus Infections (blood)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (blood)</term>
<term>Pneumonia, Viral (epidemiology)</term>
<term>Procalcitonin (blood)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen (MeSH)</term>
<term>Antibactériens (usage thérapeutique)</term>
<term>Femelle (MeSH)</term>
<term>Gestion responsable des antimicrobiens (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Infections à coronavirus (sang)</term>
<term>Infections à coronavirus (traitement médicamenteux)</term>
<term>Infections à coronavirus (épidémiologie)</term>
<term>Marqueurs biologiques (sang)</term>
<term>Mâle (MeSH)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (sang)</term>
<term>Pneumopathie virale (épidémiologie)</term>
<term>Procalcitonine (sang)</term>
<term>Protéine C-réactive (analyse)</term>
<term>Sujet âgé (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>C-Reactive Protein</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Biomarkers</term>
<term>Procalcitonin</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Bacterial Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="analyse" xml:lang="fr"><term>Protéine C-réactive</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Marqueurs biologiques</term>
<term>Pneumopathie virale</term>
<term>Procalcitonine</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antibactériens</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Antimicrobial Stewardship</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Pandemics</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Femelle</term>
<term>Gestion responsable des antimicrobiens</term>
<term>Humains</term>
<term>Mâle</term>
<term>Pandémies</term>
<term>Sujet âgé</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33023606</PMID>
<DateCompleted><Year>2020</Year>
<Month>10</Month>
<Day>13</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>10</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>24</Volume>
<Issue>1</Issue>
<PubDate><Year>2020</Year>
<Month>10</Month>
<Day>06</Day>
</PubDate>
</JournalIssue>
<Title>Critical care (London, England)</Title>
<ISOAbbreviation>Crit Care</ISOAbbreviation>
</Journal>
<ArticleTitle>Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 times?</ArticleTitle>
<Pagination><MedlinePgn>600</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-020-03291-w</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>van Berkel</LastName>
<ForeName>Miranda</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Department of Laboratory Medicine, Radboud University Medical Centre, 6500 HB, Nijmegen, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kox</LastName>
<ForeName>Matthijs</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Radboud University Medical Centre, Postbus 9101, 6500 HB, Nijmegen, The Netherlands.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Radboud Center for Infectious Diseases, Radboud University Medical Center, 6500 HB, Nijmegen, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Frenzel</LastName>
<ForeName>Tim</ForeName>
<Initials>T</Initials>
<AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Radboud University Medical Centre, Postbus 9101, 6500 HB, Nijmegen, The Netherlands.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Radboud Center for Infectious Diseases, Radboud University Medical Center, 6500 HB, Nijmegen, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Pickkers</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Radboud University Medical Centre, Postbus 9101, 6500 HB, Nijmegen, The Netherlands.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Radboud Center for Infectious Diseases, Radboud University Medical Center, 6500 HB, Nijmegen, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Schouten</LastName>
<ForeName>Jeroen</ForeName>
<Initials>J</Initials>
<Identifier Source="ORCID">0000-0001-9118-4420</Identifier>
<AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Radboud University Medical Centre, Postbus 9101, 6500 HB, Nijmegen, The Netherlands. jeroen.schouten@radboudumc.nl.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Radboud Center for Infectious Diseases, Radboud University Medical Center, 6500 HB, Nijmegen, The Netherlands. jeroen.schouten@radboudumc.nl.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><CollectiveName>RCI-COVID-19 study group</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>10</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Crit Care</MedlineTA>
<NlmUniqueID>9801902</NlmUniqueID>
<ISSNLinking>1364-8535</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000077740">Procalcitonin</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>9007-41-4</RegistryNumber>
<NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073602" MajorTopicYN="Y">Antimicrobial Stewardship</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002097" MajorTopicYN="N">C-Reactive Protein</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000077740" MajorTopicYN="N">Procalcitonin</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Antimicrobial stewardship</Keyword>
<Keyword MajorTopicYN="Y">COVID-19</Keyword>
<Keyword MajorTopicYN="Y">Procalcitonin</Keyword>
</KeywordList>
<InvestigatorList><Investigator ValidYN="Y"><LastName>van Berkel</LastName>
<ForeName>Miranda</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kox</LastName>
<ForeName>Matthijs</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Frenzel</LastName>
<ForeName>Tim</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Pickkers</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Schouten</LastName>
<ForeName>Jeroen</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Waanders</LastName>
<ForeName>Denise</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Bruse</LastName>
<ForeName>Niklas</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kooistra</LastName>
<ForeName>Emma</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Touw</LastName>
<ForeName>Hugo</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Hemelaar</LastName>
<ForeName>Pleun</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Beunders</LastName>
<ForeName>Remi</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>van der Hoeven</LastName>
<ForeName>Johannes</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>van der Velde</LastName>
<ForeName>Sjef</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>van der Eng</LastName>
<ForeName>Hetty</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Rovers</LastName>
<ForeName>Noortje</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Klop-Riehl</LastName>
<ForeName>Margreet</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gerretsen</LastName>
<ForeName>Jelle</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Waalders</LastName>
<ForeName>Nicole</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Claassen</LastName>
<ForeName>Wout</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Heesakkers</LastName>
<ForeName>Hidde</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>van Schaik</LastName>
<ForeName>Tirsa</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Netea</LastName>
<ForeName>Mihai</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Joosten</LastName>
<ForeName>Leo</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Janssen</LastName>
<ForeName>Nico</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Grondman</LastName>
<ForeName>Inge</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>de Nooijer</LastName>
<ForeName>Aline</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>de Mast</LastName>
<ForeName>Quirijn</ForeName>
<Initials>Q</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Jaeger</LastName>
<ForeName>Martin</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kouijzer</LastName>
<ForeName>Ilse</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Dijkstra</LastName>
<ForeName>Helga</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Lemmers</LastName>
<ForeName>Heidi</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>van Crevel</LastName>
<ForeName>Reinout</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>van de Maat</LastName>
<ForeName>Josephine</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Nijman</LastName>
<ForeName>Gerine</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Moorlag</LastName>
<ForeName>Simone</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Taks</LastName>
<ForeName>Esther</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Debisarun</LastName>
<ForeName>Priya</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Wertheim</LastName>
<ForeName>Heiman</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Hopman</LastName>
<ForeName>Joost</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Rahamat-Langendoen</LastName>
<ForeName>Janette</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Bleeker-Rovers</LastName>
<ForeName>Chantal</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Fasse</LastName>
<ForeName>Esther</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>van Rijssen</LastName>
<ForeName>Esther</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kolkman</LastName>
<ForeName>Manon</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>van Cranenbroek</LastName>
<ForeName>Bram</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Smeets</LastName>
<ForeName>Ruben</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Joosten</LastName>
<ForeName>Irma</ForeName>
<Initials>I</Initials>
</Investigator>
</InvestigatorList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>08</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>09</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>10</Month>
<Day>7</Day>
<Hour>5</Hour>
<Minute>33</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>10</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>10</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">33023606</ArticleId>
<ArticleId IdType="doi">10.1186/s13054-020-03291-w</ArticleId>
<ArticleId IdType="pii">10.1186/s13054-020-03291-w</ArticleId>
<ArticleId IdType="pmc">PMC7538269</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Lancet Infect Dis. 2016 Jul;16(7):819-827</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26947523</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2020 May 02;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32358954</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Microbiol Infect. 2020 Jul;26(7):808-810</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32360446</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Med. 2011 Sep 22;9:107</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21936959</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 Mar 17;323(11):1061-1069</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32031570</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Chem Lab Med. 2020 Jun 25;58(7):1131-1134</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32119647</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Pays-Bas</li>
</country>
<region><li>Gueldre</li>
</region>
<settlement><li>Nimègue</li>
</settlement>
</list>
<tree><country name="Pays-Bas"><region name="Gueldre"><name sortKey="Van Berkel, Miranda" sort="Van Berkel, Miranda" uniqKey="Van Berkel M" first="Miranda" last="Van Berkel">Miranda Van Berkel</name>
</region>
<name sortKey="Frenzel, Tim" sort="Frenzel, Tim" uniqKey="Frenzel T" first="Tim" last="Frenzel">Tim Frenzel</name>
<name sortKey="Frenzel, Tim" sort="Frenzel, Tim" uniqKey="Frenzel T" first="Tim" last="Frenzel">Tim Frenzel</name>
<name sortKey="Kox, Matthijs" sort="Kox, Matthijs" uniqKey="Kox M" first="Matthijs" last="Kox">Matthijs Kox</name>
<name sortKey="Kox, Matthijs" sort="Kox, Matthijs" uniqKey="Kox M" first="Matthijs" last="Kox">Matthijs Kox</name>
<name sortKey="Pickkers, Peter" sort="Pickkers, Peter" uniqKey="Pickkers P" first="Peter" last="Pickkers">Peter Pickkers</name>
<name sortKey="Pickkers, Peter" sort="Pickkers, Peter" uniqKey="Pickkers P" first="Peter" last="Pickkers">Peter Pickkers</name>
<name sortKey="Schouten, Jeroen" sort="Schouten, Jeroen" uniqKey="Schouten J" first="Jeroen" last="Schouten">Jeroen Schouten</name>
<name sortKey="Schouten, Jeroen" sort="Schouten, Jeroen" uniqKey="Schouten J" first="Jeroen" last="Schouten">Jeroen Schouten</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidSeniorV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000898 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000898 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidSeniorV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:33023606 |texte= Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 times? }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:33023606" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a CovidSeniorV1
This area was generated with Dilib version V0.6.37. |